{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:39:31Z","timestamp":1791243571130,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["VIDI grant 016.156.415"],"award-info":[{"award-number":["VIDI grant 016.156.415"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["VICI grant 17854 \/ No. 2020\/TTW\/00836465"],"award-info":[{"award-number":["VICI grant 17854 \/ No. 2020\/TTW\/00836465"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["\u201cMENTALPRECISION\u201d 10100118"],"award-info":[{"award-number":["\u201cMENTALPRECISION\u201d 10100118"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust Collaborative Award","award":["215573\/Z\/19\/Z"],"award-info":[{"award-number":["215573\/Z\/19\/Z"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative disorder with motor symptoms (e.g., bradykinesia, tremors) and non-motor symptoms (e.g., cognitive deficits). Symptom progression varies across individuals, possibly due to differences in the spread of disease pathology. This study investigates individual-level gray matter atrophy in PD patients compared to a reference cohort, modeling neurobiological trajectories to understand symptom progression. Using normative modeling, we mapped individual deviations in gray matter atrophy in PD patients (Personalized Parkinson Project, PPP; N\u2009=\u2009408; 42% female) against a reference model (N\u2009=\u200958, 836) of non-diagnosed individuals. Gray matter atrophy was defined as negative deviations from the normative model in cortical thickness and subcortical volume at baseline and two-year follow-up. We correlated the deviations with clinical motor and cognitive symptoms at an individual level and compared changes across PD subtypes (mild-motor predominant, intermediate, and diffuse-malignant). Cross-sectionally, PD patients showed significant gray matter atrophy, which correlated with cognitive impairment. Longitudinally, cortical thinning and subcortical atrophy patterns showed variation amongst subtypes. Specifically, the diffuse-malignant subtype, which is characterized by more diffuse symptoms and faster clinical progression, exhibited pronounced cortical thinning and subcortical atrophy over time. In this paper, we have considered the deviation scores at three levels of granularity: cases vs. control, subtypes, and the individual level. While our findings show subgroup-level patterns of variability, they also provide a method for exploring individual-level metrics of disease progression, acknowledging that individuals may deviate from the predefined categories or groups and can exhibit large variability over time.<\/jats:p>","DOI":"10.1038\/s41598-025-20484-x","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:17:25Z","timestamp":1761038245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Understanding individual neurodegenerative progression in Parkinson\u2019s disease through normative modelling"],"prefix":"10.1038","volume":"15","author":[{"given":"Charlotte","family":"Fraza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora Reh\u00e1k","family":"Bu\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick C.","family":"Helmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Marquand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"20484_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00441-018-2817-y","volume":"373","author":"KJ Billingsley","year":"2018","unstructured":"Billingsley, K. J., Bandres-Ciga, S., Saez-Atienzar, S. & Singleton, A. B. Genetic risk factors in Parkinson\u2019s disease. Cell Tissue Res 373, 9\u201320 (2018).","journal-title":"Cell Tissue Res"},{"key":"20484_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. The Lancet 397, 2284\u20132303 (2021).","journal-title":"The Lancet"},{"key":"20484_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/jnnp.2003.033530","volume":"76","author":"SJG Lewis","year":"2005","unstructured":"Lewis, S. J. G. et al. Heterogeneity of Parkinson\u2019s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76, 343\u2013348 (2005).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20484_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00702-023-02635-4","volume":"130","author":"U W\u00fcllner","year":"2023","unstructured":"W\u00fcllner, U. et al. The heterogeneity of Parkinson\u2019s disease. J Neural Transm (Vienna) 130, 827\u2013838 (2023).","journal-title":"J Neural Transm (Vienna)"},{"key":"20484_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-022-00328-8","volume":"12","author":"I Frigerio","year":"2023","unstructured":"Frigerio, I. et al. Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson\u2019s disease dementia. Translational Neurodegeneration 12, 3 (2023).","journal-title":"Translational Neurodegeneration"},{"key":"20484_CR6","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1002\/mds.28706","volume":"36","author":"MA Laansma","year":"2021","unstructured":"Laansma, M. A. et al. International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson\u2019s Disease. Mov Disord 36, 2583\u20132594 (2021).","journal-title":"Mov Disord"},{"key":"20484_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101986","volume":"24","author":"Y Zeighami","year":"2019","unstructured":"Zeighami, Y. et al. Assessment of a prognostic MRI biomarker in early de novo Parkinson\u2019s disease. Neuroimage Clin 24, 101986 (2019).","journal-title":"Neuroimage Clin"},{"key":"20484_CR8","first-page":"504","volume":"40","author":"G DeMaagd","year":"2015","unstructured":"DeMaagd, G. & Philip, A. Parkinson\u2019s Disease and Its Management. P T 40, 504\u2013532 (2015).","journal-title":"P T"},{"key":"20484_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/ejn.14094","volume":"49","author":"JC Greenland","year":"2019","unstructured":"Greenland, J. C., Williams-Gray, C. H. & Barker, R. A. The clinical heterogeneity of Parkinson\u2019s disease and its therapeutic implications. Eur. J. Neurosci. 49, 328\u2013338 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"20484_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma, R. B. & Berg, D. Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12, 622\u2013634 (2016).","journal-title":"Nat Rev Neurol"},{"key":"20484_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat Rev Neurosci 18, 435\u2013450 (2017).","journal-title":"Nat Rev Neurosci"},{"key":"20484_CR12","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"S-M Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad, S.-M., Zeighami, Y., Dagher, A. & Postuma, R. B. Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140, 1959\u20131976 (2017).","journal-title":"Brain"},{"key":"20484_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.biopsych.2015.12.023","volume":"80","author":"AF Marquand","year":"2016","unstructured":"Marquand, A. F., Rezek, I., Buitelaar, J. & Beckmann, C. F. Understanding Heterogeneity in Clinical Cohorts Using Normative Models: Beyond Case-Control Studies. Biol Psychiatry 80, 552\u2013561 (2016).","journal-title":"Biol Psychiatry"},{"key":"20484_CR14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41380-019-0441-1","volume":"24","author":"AF Marquand","year":"2019","unstructured":"Marquand, A. F. et al. Conceptualizing mental disorders as deviations from normative functioning. Mol Psychiatry 24, 1415\u20131424 (2019).","journal-title":"Mol Psychiatry"},{"key":"20484_CR15","doi-asserted-by":"publisher","first-page":"e72904","DOI":"10.7554\/eLife.72904","volume":"11","author":"S Rutherford","year":"2022","unstructured":"Rutherford, S. et al. Charting brain growth and aging at high spatial precision. Elife 11, e72904 (2022).","journal-title":"Elife"},{"key":"20484_CR16","doi-asserted-by":"publisher","first-page":"15746","DOI":"10.1038\/s41598-021-95098-0","volume":"11","author":"WHL Pinaya","year":"2021","unstructured":"Pinaya, W. H. L. et al. Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer\u2019s disease in a cross-sectional multi-cohort study. Sci Rep 11, 15746 (2021).","journal-title":"Sci Rep"},{"key":"20484_CR17","doi-asserted-by":"publisher","unstructured":"Verdi, S. et al. Personalising Alzheimer\u2019s Disease progression using brain atrophy markers. 2023.06.15.23291418 Preprint at https:\/\/doi.org\/10.1101\/2023.06.15.23291418 (2023).","DOI":"10.1101\/2023.06.15.23291418"},{"key":"20484_CR18","doi-asserted-by":"publisher","unstructured":"Bu, X. et al. Normative growth modeling of brain morphology reveals neuroanatomical heterogeneity and biological subtypes in children with ADHD. 2024.03.16.582202 Preprint at https:\/\/doi.org\/10.1101\/2024.03.16.582202 (2024).","DOI":"10.1101\/2024.03.16.582202"},{"key":"20484_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1176\/appi.ajp.2020.20070999","volume":"178","author":"Y-H Tung","year":"2021","unstructured":"Tung, Y.-H. et al. Whole Brain White Matter Tract Deviation and Idiosyncrasy From Normative Development in Autism and ADHD and Unaffected Siblings Link With Dimensions of Psychopathology and Cognition. AJP 178, 730\u2013743 (2021).","journal-title":"AJP"},{"key":"20484_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1017\/S0033291719000084","volume":"50","author":"T Wolfers","year":"2020","unstructured":"Wolfers, T. et al. Individual differences v. the average patient: mapping the heterogeneity in ADHD using normative models. Psychol Med. 50, 314\u2013323 (2020).","journal-title":"Psychol Med."},{"key":"20484_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s42003-020-01212-9","volume":"3","author":"RAI Bethlehem","year":"2020","unstructured":"Bethlehem, R. A. I. et al. A normative modelling approach reveals age-atypical cortical thickness in a subgroup of males with autism spectrum disorder. Commun Biol 3, 486 (2020).","journal-title":"Commun Biol"},{"key":"20484_CR22","first-page":"802","volume":"6","author":"DL Floris","year":"2021","unstructured":"Floris, D. L. et al. Atypical Brain Asymmetry in Autism\u2014A Candidate for Clinically Meaningful Stratification. Biol. Psychiatry: Cognitive Neurosci. Neuroimag. 6, 802\u2013812 (2021).","journal-title":"Biol. Psychiatry: Cognitive Neurosci. Neuroimag."},{"key":"20484_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-01057-0","volume":"10","author":"M Zabihi","year":"2020","unstructured":"Zabihi, M. et al. Fractionating autism based on neuroanatomical normative modeling. Transl Psychiatry 10, 1\u201310 (2020).","journal-title":"Transl Psychiatry"},{"key":"20484_CR24","doi-asserted-by":"crossref","unstructured":"Bu\u010dkov\u00e1, B. R. et al. Using normative models pre-trained on cross-sectional data to evaluate longitudinal changes in neuroimaging data. eLife 13, (2024).","DOI":"10.7554\/eLife.95823.1"},{"key":"20484_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/jamapsychiatry.2018.2467","volume":"75","author":"T Wolfers","year":"2018","unstructured":"Wolfers, T. et al. Mapping the Heterogeneous Phenotype of Schizophrenia and Bipolar Disorder Using Normative Models. JAMA Psychiat. 75, 1146\u20131155 (2018).","journal-title":"JAMA Psychiat."},{"key":"20484_CR26","doi-asserted-by":"publisher","unstructured":"Fraza, C., S\u00f8nderby, I. E., Boen, R., Beckmann, C. F. & Marquand, A. F. Unraveling the Link between CNVs, General Cognition, and Individual Neuroimaging Deviation Scores from a Reference Cohort. 2023.11.29.23298954 Preprint at https:\/\/doi.org\/10.1101\/2023.11.29.23298954 (2023).","DOI":"10.1101\/2023.11.29.23298954"},{"key":"20484_CR27","doi-asserted-by":"publisher","first-page":"e2442","DOI":"10.1212\/WNL.0000000000207298","volume":"100","author":"S Verdi","year":"2023","unstructured":"Verdi, S. et al. Revealing Individual Neuroanatomical Heterogeneity in Alzheimer Disease Using Neuroanatomical Normative Modeling. Neurology 100, e2442\u2013e2453 (2023).","journal-title":"Neurology"},{"key":"20484_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-023-01410-8","author":"NE Holz","year":"2023","unstructured":"Holz, N. E. et al. A stable and replicable neural signature of lifespan adversity in the adult brain. Nat Neurosci. https:\/\/doi.org\/10.1038\/s41593-023-01410-8 (2023).","journal-title":"Nat Neurosci."},{"key":"20484_CR29","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.biopsych.2023.05.021","volume":"94","author":"X Sun","year":"2023","unstructured":"Sun, X. et al. Mapping Neurophysiological Subtypes of Major Depressive Disorder Using Normative Models of the Functional Connectome. Biol. Psychiat. 94, 936\u2013947 (2023).","journal-title":"Biol. Psychiat."},{"key":"20484_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106284","volume":"176","author":"C Fraza","year":"2025","unstructured":"Fraza, C., Rutherford, S., Bu\u010dkov\u00e1, B. R., Beckmann, C. F. & Marquand, A. F. The promise of quantifying individual risk for brain disorders through normative modeling, a narrative review. Neurosci. Biobehav. Rev. 176, 106284 (2025).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"20484_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"S-M Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad, S.-M. et al. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. JAMA Neurol 72, 863\u2013873 (2015).","journal-title":"JAMA Neurol"},{"key":"20484_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-023-00466-4","volume":"9","author":"ME Johansson","year":"2023","unstructured":"Johansson, M. E., van Lier, N. M., Kessels, R. P. C., Bloem, B. R. & Helmich, R. C. Two-year clinical progression in focal and diffuse subtypes of Parkinson\u2019s disease. npj Parkinsons Dis. 9, 1\u201311 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"20484_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","volume":"76","author":"E De Pablo-Fern\u00e1ndez","year":"2019","unstructured":"De Pablo-Fern\u00e1ndez, E., Lees, A. J., Holton, J. L. & Warner, T. T. Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease. JAMA Neurol 76, 470\u2013479 (2019).","journal-title":"JAMA Neurol"},{"key":"20484_CR34","doi-asserted-by":"publisher","unstructured":"Johansson, M. E., Toni, I., Kessels, R. P. C., Bloem, B. R. & Helmich, R. C. Clinical severity in Parkinson\u2019s disease is determined by decline in cortical compensation. 2023.04.16.23288636 Preprint at https:\/\/doi.org\/10.1101\/2023.04.16.23288636 (2023).","DOI":"10.1101\/2023.04.16.23288636"},{"key":"20484_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000495","volume":"17","author":"Y-Q Zheng","year":"2019","unstructured":"Zheng, Y.-Q. et al. Local vulnerability and global connectivity jointly shape neurodegenerative disease propagation. PLoS Biol 17, e3000495 (2019).","journal-title":"PLoS Biol"},{"key":"20484_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/03014460.2023.2190619","volume":"50","author":"S Van Buuren","year":"2023","unstructured":"Van Buuren, S. Evaluation and prediction of individual growth trajectories. Ann. Hum. Biol. 50, 247\u2013257 (2023).","journal-title":"Ann. Hum. Biol."},{"key":"20484_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12883-019-1394-3","volume":"19","author":"BR Bloem","year":"2019","unstructured":"Bloem, B. R. et al. The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson\u2019s disease. BMC Neurol. 19, 160 (2019).","journal-title":"BMC Neurol."},{"key":"20484_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroimage.2010.06.010","volume":"53","author":"C Destrieux","year":"2010","unstructured":"Destrieux, C., Fischl, B., Dale, A. & Halgren, E. Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. Neuroimage 53, 1\u201315 (2010).","journal-title":"Neuroimage"},{"key":"20484_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.neuroimage.2017.12.059","volume":"169","author":"AFG Rosen","year":"2018","unstructured":"Rosen, A. F. G. et al. Quantitative assessment of structural image quality. Neuroimage 169, 407\u2013418 (2018).","journal-title":"Neuroimage"},{"key":"20484_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278776","volume":"17","author":"SM Kia","year":"2022","unstructured":"Kia, S. M. et al. Closing the life-cycle of normative modeling using federated hierarchical Bayesian regression. PLoS ONE 17, e0278776 (2022).","journal-title":"PLoS ONE"},{"key":"20484_CR41","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"20484_CR42","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695\u2013699 (2005).","journal-title":"J Am Geriatr Soc"},{"key":"20484_CR43","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/brain\/awad325","volume":"147","author":"ME Johansson","year":"2024","unstructured":"Johansson, M. E., Toni, I., Kessels, R. P. C., Bloem, B. R. & Helmich, R. C. Clinical severity in Parkinson\u2019s disease is determined by decline in cortical compensation. Brain 147, 871\u2013886 (2024).","journal-title":"Brain"},{"key":"20484_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118715","volume":"245","author":"CJ Fraza","year":"2021","unstructured":"Fraza, C. J., Dinga, R., Beckmann, C. F. & Marquand, A. F. Warped Bayesian linear regression for normative modelling of big data. Neuroimage 245, 118715 (2021).","journal-title":"Neuroimage"},{"key":"20484_CR45","doi-asserted-by":"publisher","unstructured":"Dinga, R. et al. Normative modeling of neuroimaging data using generalized additive models of location scale and shape. 2021.06.14.448106 Preprint at https:\/\/doi.org\/10.1101\/2021.06.14.448106 (2021).","DOI":"10.1101\/2021.06.14.448106"},{"key":"20484_CR46","doi-asserted-by":"publisher","unstructured":"Gaiser, C. et al. Estimating cortical thickness trajectories in children across different scanners using transfer learning from normative models. 2023.03.02.530742 Preprint at https:\/\/doi.org\/10.1101\/2023.03.02.530742 (2023).","DOI":"10.1101\/2023.03.02.530742"},{"key":"20484_CR47","first-page":"433","volume":"1","author":"AF Marquand","year":"2016","unstructured":"Marquand, A. F., Wolfers, T., Mennes, M., Buitelaar, J. & Beckmann, C. F. Beyond Lumping and Splitting: A Review of Computational Approaches for Stratifying Psychiatric Disorders. Biol Psychiatry Cogn Neurosci Neuroimaging 1, 433\u2013447 (2016).","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"20484_CR48","unstructured":"Free Icons and Stickers - Millions of resources to download. Flaticon https:\/\/www.flaticon.com\/."},{"key":"20484_CR49","unstructured":"SlidesCarnival: Free PowerPoint & Google Slides Templates That Stand Out. https:\/\/www.slidescarnival.com\/."},{"key":"20484_CR50","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"K Marek","year":"2011","unstructured":"Marek, K. et al. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 95, 629\u2013635 (2011).","journal-title":"Prog Neurobiol"},{"key":"20484_CR51","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1002\/hbm.22397","volume":"35","author":"DM Herz","year":"2014","unstructured":"Herz, D. M., Eickhoff, S. B., L\u00f8kkegaard, A. & Siebner, H. R. Functional neuroimaging of motor control in Parkinson\u2019s disease: a meta-analysis. Hum Brain Mapp 35, 3227\u20133237 (2014).","journal-title":"Hum Brain Mapp"},{"key":"20484_CR52","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1002\/hbm.22449","volume":"35","author":"C Tessa","year":"2014","unstructured":"Tessa, C. et al. Progression of brain atrophy in the early stages of Parkinson\u2019s disease: A longitudinal tensor-based morphometry study in de novo patients without cognitive impairment. Hum Brain Mapp 35, 3932\u20133944 (2014).","journal-title":"Hum Brain Mapp"},{"key":"20484_CR53","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/mds.25982","volume":"29","author":"B Segura","year":"2014","unstructured":"Segura, B. et al. Cortical thinning associated with mild cognitive impairment in Parkinson\u2019s disease. Mov Disord 29, 1495\u20131503 (2014).","journal-title":"Mov Disord"},{"key":"20484_CR54","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.neuroimage.2010.12.043","volume":"55","author":"T Jubault","year":"2011","unstructured":"Jubault, T. et al. Patterns of cortical thickness and surface area in early Parkinson\u2019s disease. Neuroimage 55, 462\u2013467 (2011).","journal-title":"Neuroimage"},{"key":"20484_CR55","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/brain\/aww175","volume":"139","author":"RS Weil","year":"2016","unstructured":"Weil, R. S. et al. Visual dysfunction in Parkinson\u2019s disease. Brain 139, 2827\u20132843 (2016).","journal-title":"Brain"},{"key":"20484_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-00234-1","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7, 1\u201321 (2021).","journal-title":"Nat Rev Dis Primers"},{"key":"20484_CR57","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.neuroimage.2003.12.014","volume":"21","author":"M Carbon","year":"2004","unstructured":"Carbon, M. et al. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage 21, 1497\u20131507 (2004).","journal-title":"Neuroimage"},{"key":"20484_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fnsys.2015.00138","volume":"9","author":"A Hanganu","year":"2015","unstructured":"Hanganu, A., Provost, J.-S. & Monchi, O. Neuroimaging studies of striatum in cognition part II: Parkinson\u2019s disease. Front. Syst. Neurosci. 9, 138 (2015).","journal-title":"Front. Syst. Neurosci."},{"key":"20484_CR59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neuroimage.2013.03.070","volume":"78","author":"M Niethammer","year":"2013","unstructured":"Niethammer, M. et al. Parkinson\u2019s Disease Cognitive Network Correlates with Caudate Dopamine. Neuroimage 78, 204\u2013209 (2013).","journal-title":"Neuroimage"},{"key":"20484_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.22361","volume":"69","author":"RC Helmich","year":"2011","unstructured":"Helmich, R. C., Janssen, M. J. R., Oyen, W. J. G., Bloem, B. R. & Toni, I. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 69, 269\u2013281 (2011).","journal-title":"Ann Neurol"},{"key":"20484_CR61","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1002\/ana.10489","volume":"53","author":"WG Tatton","year":"2003","unstructured":"Tatton, W. G., Chalmers-Redman, R., Brown, D. & Tatton, N. Apoptosis in Parkinson\u2019s disease: Signals for neuronal degradation. Ann. Neurol. 53, S61\u2013S72 (2003).","journal-title":"Ann. Neurol."},{"key":"20484_CR62","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/mds.28468","volume":"36","author":"DM Herz","year":"2021","unstructured":"Herz, D. M., Meder, D., Camilleri, J. A., Eickhoff, S. B. & Siebner, H. R. Brain Motor Network Changes in Parkinson\u2019s Disease: Evidence from Meta-Analytic Modeling. Mov. Disord. 36, 1180\u20131190 (2021).","journal-title":"Mov. Disord."},{"key":"20484_CR63","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","volume":"18","author":"NM van der Kolk","year":"2019","unstructured":"van der Kolk, N. M. et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson\u2019s disease: a double-blind, randomised controlled trial. Lancet Neurol 18, 998\u20131008 (2019).","journal-title":"Lancet Neurol"},{"key":"20484_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ana.26291","volume":"91","author":"ME Johansson","year":"2022","unstructured":"Johansson, M. E. et al. Aerobic Exercise Alters Brain Function and Structure in Parkinson\u2019s Disease: A Randomized Controlled Trial. Ann Neurol 91, 203\u2013216 (2022).","journal-title":"Ann Neurol"},{"key":"20484_CR65","doi-asserted-by":"publisher","first-page":"9537","DOI":"10.1038\/s41598-023-31531-w","volume":"13","author":"C Gabbert","year":"2023","unstructured":"Gabbert, C. et al. Lifestyle factors and clinical severity of Parkinson\u2019s disease. Sci Rep 13, 9537 (2023).","journal-title":"Sci Rep"},{"key":"20484_CR66","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1038\/s41598-024-65640-x","volume":"14","author":"C Gabbert","year":"2024","unstructured":"Gabbert, C. et al. The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson\u2019s disease. Sci Rep 14, 14670 (2024).","journal-title":"Sci Rep"},{"key":"20484_CR67","doi-asserted-by":"publisher","unstructured":"Rutherford, S. et al. To which reference class do you belong? Measuring racial fairness of reference classes with normative modeling. Preprint at https:\/\/doi.org\/10.48550\/arXiv.2407.19114 (2024).","DOI":"10.48550\/arXiv.2407.19114"},{"key":"20484_CR68","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2024.1698","author":"SS Haas","year":"2024","unstructured":"Haas, S. S., Ge, R. & Frangou, S. Brain Morphometry Normative Modeling\u2014Omit Global Thickness\u2014Reply. JAMA Psychiat. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.1698 (2024).","journal-title":"JAMA Psychiat."},{"key":"20484_CR69","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s44220-024-00322-1","volume":"2","author":"C Fraza","year":"2024","unstructured":"Fraza, C. et al. Unraveling the link between CNVs, cognition and individual neuroimaging deviation scores from a population-based reference cohort. Nat. Mental Health 2, 1451\u20131463 (2024).","journal-title":"Nat. Mental Health"},{"key":"20484_CR70","doi-asserted-by":"publisher","unstructured":"Kia, S. M. et al. Hierarchical Bayesian Regression for Multi-site Normative Modeling of Neuroimaging Data. in Medical Image Computing and Computer Assisted Intervention \u2013 MICCAI 2020 (eds. Martel, A. L. et al.) 699\u2013709 (Springer International Publishing, Cham, 2020). https:\/\/doi.org\/10.1007\/978-3-030-59728-3_68.","DOI":"10.1007\/978-3-030-59728-3_68"},{"key":"20484_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/imag_a_00344","volume":"2","author":"AAA de Boer","year":"2024","unstructured":"de Boer, A. A. A. et al. Non-Gaussian normative modelling with hierarchical Bayesian regression. Imag. Neurosci. 2, 1\u201336 (2024).","journal-title":"Imag. Neurosci."},{"key":"20484_CR72","doi-asserted-by":"publisher","first-page":"923988","DOI":"10.3389\/fneur.2022.923988","volume":"13","author":"JMM Bayer","year":"2022","unstructured":"Bayer, J. M. M. et al. Site effects how-to and when: An overview of retrospective techniques to accommodate site effects in multi-site neuroimaging analyses. Front. Neurol. 13, 923988 (2022).","journal-title":"Front. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20484-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:04:24Z","timestamp":1761041064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20484-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20484"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20484-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CFB is a director of and shareholder in SBGneuro Ltd. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36659"}}